Mahickra Chemicals Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Mahickra Chemicals 0.26% cari getiri oranına sahip temettü ödeyen bir şirkettir.

Anahtar bilgiler

0.3%

Temettü verimi

-0.02%

Geri Alım Getirisi

Toplam Hissedar Getirisi	0.2%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	0.3%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	₹0.300
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Feb 27

Recent updates

These 4 Measures Indicate That Mahickra Chemicals (NSE:MAHICKRA) Is Using Debt Reasonably Well

Oct 30

Mahickra Chemicals Limited's (NSE:MAHICKRA) Share Price Not Quite Adding Up

Jul 02

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

Jan 30

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Jan 19

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Jun 14

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Apr 04

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Feb 27

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Feb 06

How Does Mahickra Chemicals Limited (NSE:MAHICKRA) Stand Up To These Simple Dividend Safety Checks?

Jan 31

Should You Take Comfort From Insider Transactions At Mahickra Chemicals Limited (NSE:MAHICKRA)?

Jan 04

Mahickra Chemicals Limited's (NSE:MAHICKRA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: MAHICKRA 10 yıldan az bir süredir temettü ödüyor ve bu süre zarfında ödemeler dalgalı oldu.

Büyüyen Temettü: MAHICKRA yalnızca 4 yıldır temettü ödüyor ve o zamandan beri ödemeler artmadı.

Piyasaya Karşı Temettü Getirisi

Mahickra Chemicals Piyasaya Karşı Temettü Getirisi

MAHICKRA temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (MAHICKRA)	0.3%
Pazarın Alt %25'i (IN)	0.2%
Pazarın En İyi %25'i (IN)	1.1%
Sektör Ortalaması (Chemicals)	0.7%
Analist tahmini (MAHICKRA) (3 yıla kadar)	n/a

Önemli Temettü: MAHICKRA 'in temettüsü ( 0.26% ), Indian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 0.24% ) daha yüksektir.

Yüksek Temettü: MAHICKRA 'in temettüsü ( 0.26% ), Indian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 1.11% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: MAHICKRA herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Düşük nakit ödeme oranı ( 16.3% ) sayesinde MAHICKRA 'un temettü ödemeleri nakit akışları tarafından iyi bir şekilde karşılanmaktadır.

Güçlü temettü ödeyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/25 07:46
Gün Sonu Hisse Fiyatı	2024/12/24 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2024/03/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Mahickra Chemicals Limited 0 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum

Mahickra Chemicals Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Recent updates

Whole-Time Director recently sold ₹4.0m worth of stock

Whole-Time Director recently sold ₹4.1m worth of stock

Whole-Time Director recently sold ₹4.0m worth of stock

New major risk - Market cap size

Whole-Time Director recently sold ₹3.8m worth of stock

These 4 Measures Indicate That Mahickra Chemicals (NSE:MAHICKRA) Is Using Debt Reasonably Well

First half 2025 earnings released: EPS: ₹1.66 (vs ₹0.60 in 1H 2024)

New major risk - Dividend sustainability

Mahickra Chemicals Limited, Annual General Meeting, Sep 21, 2024

Whole-Time Director recently sold ₹5.0m worth of stock

Whole-Time Director recently sold ₹7.7m worth of stock

New minor risk - Insider selling

Whole-Time Director recently sold ₹599k worth of stock

Mahickra Chemicals Limited's (NSE:MAHICKRA) Share Price Not Quite Adding Up

New major risk - Market cap size

Whole-Time Director recently sold ₹311k worth of stock

Chairman & MD recently sold ₹533k worth of stock

Full year 2024 earnings released: EPS: ₹1.32 (vs ₹4.05 in FY 2023)

Chairman & MD recently bought ₹1.3m worth of stock

New minor risk - Share price stability

New minor risk - Share price stability

Chairman & MD recently bought ₹931k worth of stock

Investor sentiment improves as stock rises 21%

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Whole-Time Director recently bought ₹157k worth of stock

First half 2024 earnings released: EPS: ₹0.60 (vs ₹1.95 in 1H 2023)

New major risk - Financial position

Whole-Time Director recently bought ₹500k worth of stock

Mahickra Chemicals Limited, Annual General Meeting, Aug 29, 2023

Chairman & MD recently bought ₹124k worth of stock

New minor risk - Share price stability

Chairman & MD recently bought ₹251k worth of stock

Whole-Time Director recently bought ₹125k worth of stock

Chairman & MD recently bought ₹134k worth of stock

Chairman & MD recently bought ₹148k worth of stock

Whole-Time Director recently bought ₹148k worth of stock

Investor sentiment improves as stock rises 18%

Chairman & MD recently bought ₹127k worth of stock

Chairman & MD recently bought ₹368k worth of stock

Chairman & MD recently bought ₹111k worth of stock

Chairman & MD recently bought ₹112k worth of stock

First half 2023 earnings released: EPS: ₹1.95 (vs ₹2.05 in 1H 2022)

Whole-Time Director recently bought ₹214k worth of stock

Whole-Time Director recently bought ₹100k worth of stock

Whole-Time Director recently bought ₹106k worth of stock

Whole-Time Director recently bought ₹216k worth of stock

Whole-Time Director recently bought ₹109k worth of stock

Chairman & MD recently bought ₹214k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Full year 2022 earnings released: EPS: ₹4.12 (vs ₹3.83 in FY 2021)

Insufficient new directors

Whole-Time Director recently bought ₹118k worth of stock

Chairman & MD recently bought ₹373k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

Whole-Time Director recently bought ₹127k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Chairman & MD recently bought ₹121k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹119k worth of stock

Chairman & MD recently bought ₹120k worth of stock

First half 2022 earnings released

Chairman & MD recently bought ₹119k worth of stock

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹129k worth of stock

Chairman & MD recently bought ₹131k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

New 90-day low: ₹77.10

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Chairman & MD recently bought ₹121k worth of stock

New 90-day low: ₹78.45